Helena Jernström
41 – 50 of 127
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
The prognostic impact of COX-2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor size
(
- Contribution to journal › Article
-
Mark
Östrogenreceptor-beta kopplad till bättre prognos vid bröstcancer
(
- Contribution to journal › Article
-
Mark
Combined and individual tumor-specific expression of insulinlike growth factor-I receptor, insulin receptor and phosphoinsulin- like growth factor-I receptor/insulin receptor in primary breast cancer : Implications for prognosis in different treatment groups
(
- Contribution to journal › Article
-
Mark
Högt ER-beta-uttryck starkt skyddande mot återfall hos de kvinnor som fått cytostatika
(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
High Estrogen Receptor β Expression Is Prognostic among Adjuvant Chemotherapy-Treated Patients-Results from a Population-Based Breast Cancer Cohort
(
- Contribution to journal › Article
- 2016
-
Mark
Impacts of smoking on endocrine treatment response in a prospective breast cancer cohort
(
- Contribution to journal › Article
-
Mark
CYP1A2 - a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients
(
- Contribution to journal › Article
-
Mark
The absence of aldehyde dehydrogenase 1 A1-positive cells in benign mammary stroma is associated with risk factors for breast cancer
(
- Contribution to journal › Article
-
Mark
Rökare med aromatashämmare mot bröstcancer hade sämre prognos
(
- Contribution to journal › Debate/Note/Editorial
- 2015
-
Mark
Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients.
(
- Contribution to journal › Article